We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Exosomes derived from human dental pulp stem cells increase flap survival with ischemia-reperfusion injuries

    Xin Shi

    Department of Prosthodontics, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000, PR China

    ,
    Guang Yang

    Department of Oral & Maxillofacial Surgery, The First Hospital of Qiqihar, Qiqihar, Heilongjiang Province, 161000, PR China

    ,
    Ming-yue Liu

    Department of Prosthodontics, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000, PR China

    ,
    Meng-tong Yuan

    Department of Prosthodontics, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000, PR China

    ,
    Dong Wang

    Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000, PR China

    &
    Xiao-feng Wang

    *Author for correspondence:

    E-mail Address: wxf_hrbmu@163.com

    Department of Stomatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000, PR China

    Published Online:https://doi.org/10.2217/rme-2022-0206

    Aim: To investigate the effect of hDPSC-Exos in flap I/R injury, a condition in which tissue damage increases after blood flow is restored to the flap after ischemia. Materials & methods: HUVECs were used to investigate the influences and mechanisms of hDPSC-Exos on cell proliferation and migration. A rat model was established to verify the role of hDPSC-Exos in flap I/R injuries in vivo. Results: hDPSC-Exos promoted the proliferation, migration and tube formation of HUVECs in a dose-dependent way by activating PI3K/AKT signaling pathway, and improved the survival and microvessel density of the flap and suppressed epithelial cell apoptosis. Conclusion: hDPSC-Exos can enhance flap repair after I/R injury. This process may be mediated by the activation of PI3K/AKT signaling pathway.

    Graphical abstract

    Plain language summary

    Skin flap transplantation is one of the most important methods of repairing refractory wounds and organ reconstruction. I/R injury and insufficiency of neovascularization significantly affect the survival of flaps. Human dental pulp stem cells (hDPSCs) are a type of mesenchymal stem cells (MSCs) present in dental pulp tissue that have attracted increasing attention. They can play a repair role in a variety of ischemic injuries and neovascularization. Exosomes are important paracrine mediators between MSCs and target cells, containing a variety of proteins, mRNA and miRNA. Recent studies have shown that some exosomes derived from MSCs can improve I/R injury, promote angiogenesis and inhibit apoptosis. This study confirmed that hDPSC-Exos could promote the proliferation, migration and tubule formation of vein endothelial cells in a dose-dependent manner. Inhibition of PI3K/AKT signaling pathway can reduce the above promoting effects, suggesting that these processes may depend on the activation of PI3K/AKT signaling pathway. In the rat model, hDPSC-Exos can significantly improve the survival rate and microvessel density of flaps, and inhibit epithelial cell apoptosis.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Schmid MH, Meuli-Simmen C, Hafner J. Repair of cutaneous defects after skin cancer surgery. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 160, 225–233 (2002).
    • 2. Veldhuizen IJ, Budo J, Kallen EJJ et al. A Systematic Review and Overview of Flap Reconstructive Techniques for Nasal Skin Defects. Facial Plast. Surg. Aesthet. Med. 23(6), 476–481 (2021).
    • 3. Tatlidede SH, Murphy AD, Mccormack MC et al. Improved survival of murine island skin flaps by prevention of reperfusion injury. Plast. Reconstr. Surg. 123(5), 1431–1439 (2009).
    • 4. Zhang F, Waller W, Lineaweaver WC. Growth factors and flap survival. Microsurgery 24(3), 162–167 (2004).
    • 5. Yoshida S, Tomokiyo A, Hasegawa D, Hamano S, Sugii H, Maeda H. Insight into the Role of Dental Pulp Stem Cells in Regenerative Therapy. Biology (Basel) 9(7), 160 (2020).
    • 6. Nito C, Sowa K, Nakajima M et al. Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia. Biomed. Pharmacother. 108, 1005–1014 (2018).
    • 7. Li Y, Zhang Y, Wang H et al. Dental Pulp Mesenchymal Stem Cells Attenuate Limb Ischemia via Promoting Capillary Proliferation and Collateral Development in a Preclinical Model. Stem Cells Int 2021, 5585255 (2021).
    • 8. Gandia C, Arminan A, Garcia-Verdugo JM et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26(3), 638–645 (2008).
    • 9. Yuan SM, Yang XT, Zhang SY et al. Therapeutic potential of dental pulp stem cells and their derivatives: insights from basic research toward clinical applications. World J. Stem Cells 14(7), 435–452 (2022).
    • 10. Bang C, Thum T. Exosomes: new players in cell-cell communication. Int. J. Biochem. Cell Biol. 44(11), 2060–2064 (2012).
    • 11. Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells 10(8), 1959 (2021).
    • 12. Lai RC, Yeo RW, Tan KH, Lim SK. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Reg. Med. 8(2), 197–209 (2013). • Evidence supports that mesenchymal stem cell-derived exosomes can alleviate tissue I/R injury.
    • 13. Bai Y, Han YD, Yan XL et al. Adipose mesenchymal stem cell-derived exosomes stimulated by hydrogen peroxide enhanced skin flap recovery in ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 500(2), 310–317 (2018).
    • 14. Alcayaga-Miranda F, Varas-Godoy M, Khoury M. Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration. Stem Cells Int. 2016, 3409169 (2016).
    • 15. Liu Z, Xu Y, Wan Y, Gao J, Chu Y, Li J. Exosomes from adipose-derived mesenchymal stem cells prevent cardiomyocyte apoptosis induced by oxidative stress. Cell Death Discov 5, 79 (2019).
    • 16. Zahran R, Ghozy A, Elkholy SS et al. Combination therapy with melatonin, stem cells and extracellular vesicles is effective in limiting renal ischemia-reperfusion injury in a rat model. Int. J. Urol. 27(11), 1039–1049 (2020).
    • 17. Alzahrani FA, El-Magd MA, Abdelfattah-Hassan A et al. Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats. Stem Cells Int. 2018, 8058979 (2018).
    • 18. Zheng Q, Zhang S, Guo WZ et al. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation. Front. Immunol. 12, 659621 (2021).
    • 19. Nakao T, Shiota M, Tatemoto Y et al. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. J. Pharmacol. Sci. 105(4), 334–341 (2007).
    • 20. Somanath PR, Razorenova OV, Chen J et al. Akt1 in endothelial cell and angiogenesis. Cell Cycle 5(5), 512–518 (2006).
    • 21. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90(12), 1243–1250 (2002).
    • 22. Zhang B, Cao H, Rao GN. 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling. Cancer Res. 65(16), 7283–7291 (2005).
    • 23. Yuan M, Zhan Y, Hu W et al. Aspirin promotes osteogenic differentiation of human dental pulp stem cells. Int. J. Mol. Med. 42(4), 1967–1976 (2018).
    • 24. Zhang M, Liu H, Cui Q et al. Tendon stem cell-derived exosomes regulate inflammation and promote the high-quality healing of injured tendon. Stem Cell Res. Ther. 11(1), 402 (2020).
    • 25. Zhao B, Zhang Y, Han S et al. Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. J. Mol. Histol. 48(2), 121–132 (2017).
    • 26. Zhang XF, Wang T, Wang ZX et al. Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1. Mol. Ther. Nucleic Acids 26, 347–359 (2021). •• Stem cell-derived exosomes promote endothelial cell proliferation and migration during wound healing.
    • 27. Sun X-H, Wang X, Zhang Y, Hui J. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Thromb. Res. 177, 23–32 (2019).
    • 28. Yamashita S, Sugiyama N, Hasegawa K, Namba Y, Kimata Y. A novel model for supermicrosurgery training: the superficial inferior epigastric artery flap in rats. J. Reconstr. Microsurg. 24(8), 537–543 (2008).
    • 29. Hsu CE, Shyu VB, Wen CJ, Wei FC, Huang XT, Cheng HY. The rat groin flap model redesigned for evaluating treatment effects on ischemia-reperfusion injury. J. Surg. Res. 222, 160–166 (2018). • A rat flap model with ischemia-reperfusion injury.
    • 30. Pu CM, Liu CW, Liang CJ et al. Adipose-Derived Stem Cells Protect Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression. J. Invest. Dermatol. 137(6), 1353–1362 (2017).
    • 31. Xian X, Gong Q, Li C, Guo B, Jiang H. Exosomes with Highly Angiogenic Potential for Possible Use in Pulp Regeneration. J. Endod. 44(5), 751–758 (2018).
    • 32. Eltzschig HK, Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat. Med. 17(11), 1391–1401 (2011).
    • 33. Van Den Heuvel MG, Buurman WA, Bast A, Van Der Hulst RR. Review: ischaemia-reperfusion injury in flap surgery. J. Plast. Reconstr. Aesthet. Surg. 62(6), 721–726 (2009).
    • 34. Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019, 9628536 (2019).
    • 35. Barzegar M, Kaur G, Gavins FNE, Wang Y, Boyer CJ, Alexander JS. Potential therapeutic roles of stem cells in ischemia-reperfusion injury. Stem Cell Res. 37, 101421 (2019).
    • 36. Lin K-C, Yip H-K, Shao P-L et al. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia–reperfusion injury. Int. J. Cardiol. 216, 173–185 (2016).
    • 37. Cai Y, Liu W, Lian L et al. Stroke treatment: is exosome therapy superior to stem cell therapy? Biochimie 179, 190–204 (2020).
    • 38. Xiong M, Zhang Q, Hu W et al. Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery. Front. Cell. Dev. Biol. 8, 574223 (2020).
    • 39. Chew JRJ, Chuah SJ, Teo KYW et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration. Acta Biomater. 89, 252–264 (2019).
    • 40. Sung BH, Ketova T, Hoshino D, Zijlstra A, Weaver AM. Directional cell movement through tissues is controlled by exosome secretion. Nat. Commun. 6, 7164 (2015).
    • 41. Hu L, Wang J, Zhou X et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci. Rep. 6, 32993 (2016).
    • 42. Zhang J, Guan J, Niu X et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J. Transl. Med. 13, 49 (2015). • Evidence supports that mesenchymal stem cell-derived exosomes have angiogenic effects.
    • 43. Zhang T, Yang X, Liu T et al. Adjudin-preconditioned neural stem cells enhance neuroprotection after ischemia reperfusion in mice. Stem Cell Res. Ther. 8(1), 248 (2017).
    • 44. Yu X, Wang X, Zeng S, Tuo X. Protective effects of primary neural stem cell treatment in ischemic stroke models. Exp. Ther. Med. 16(3), 2219–2228 (2018).
    • 45. Zhang J, Liu X, Li H et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res. Ther. 7(1), 136 (2016).
    • 46. Arslan F, Lai RC, Smeets MB et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10(3), 301–312 (2013). •• Evidence supports that mesenchymal stem cell-derived exosomes reduce I/R damage by activating the PI3K/AKT signaling pathway.
    • 47. Hou K, Li G, Zhao J et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J. Neuroinflammation 17(1), 46 (2020).
    • 48. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 124(3), 471–484 (2006).
    • 49. Averous J, Proud CG. When translation meets transformation: the mTOR story. Oncogene 25(48), 6423–6435 (2006).
    • 50. Ip CK, Cheung AN, Ngan HY, Wong AS. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30(21), 2420–2432 (2011).
    • 51. Jiang BH, Liu LZ. AKT signaling in regulating angiogenesis. Curr. Cancer Drug Targets 8(1), 19–26 (2008).
    • 52. Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2(7), a006502 (2012).
    • 53. Chen J, Crawford R, Chen C, Xiao Y. The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng. Part B Rev. 19(6), 516–528 (2013).
    • 54. Zhou F, Zhang L, Chen L et al. Prevascularized mesenchymal stem cell-sheets increase survival of random skin flaps in a nude mouse model. Am. J. Transl. Res. 11(3), 1403–1416 (2019).
    • 55. Nakagawa T, Sasaki M, Kataoka-Sasaki Y et al. Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats. Plast. Reconstr. Surg. 148(4), 799–807 (2021).
    • 56. Shen Z, Kuang S, Zhang Y et al. Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism. Bioact. Mater. 5(4), 1113–1126 (2020).
    • 57. Li S, Luo L, He Y et al. Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 54(8), e13093 (2021).
    • 58. Prasai A, Jay JW, Jupiter D, Wolf SE, El Ayadi A. Role of Exosomes in Dermal Wound Healing: A Systematic Review. J. Invest. Dermatol. 142(3 Pt A), 662–678.e8 (2022).
    • 59. Li Y, Jiang QL, Van Der Merwe L, Lou DH, Lin C. Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis. Stem Cell Res. Ther. 12(1), 28 (2021).
    • 60. Mullonkal CJ, Toledo-Pereyra LH. Akt in ischemia and reperfusion. J. Invest. Surg. 20(3), 195–203 (2007).
    • 61. Wang M, Zhang J, Gong N. Role of the PI3K/Akt signaling pathway in liver ischemia reperfusion injury: a narrative review. Ann. Palliat. Med. 11(2), 806–817 (2022).
    • 62. Chen Z, Wu J, Li S, Liu C, Ren Y. Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury. Front Pharmacol 13, 806216 (2022).
    • 63. Guo K, Ma J, Liang W. Effects of SB202190 on expression levels of IL-6 and NF-κB in flap ischemia-reperfusion injury. Exp. Ther. Med. 16(3), 2522–2526 (2018).